Podcasts about psychedelic medicine

In the 200th episode of the Psychedelic Medicine Podcast, Ismail Lourido Ali, JD joins to discuss the future of psychedelic medicine. Ismail serves as MAPS Co-Executive Director and has been actively participating in the drug policy reform movement for over a decade, informed by half a lifetime of diverse personal experience with psychedelics and other substances. In this conversation, Ismail explores the rapidly evolving landscape of psychedelic medicine, reflecting on the field's major milestones, challenges, and future possibilities. He discusses how public perception has shifted over the past decade, the role of state-level psychedelic reforms, and the tensions created by commercialization, overhype, and competing regulatory models. Much of the discussion focuses on the recent federal executive order related to psychedelic research and drug development, including what it may mean for FDA approval timelines, right-to-try access, rescheduling, and public health standards. Throughout, Ismail emphasizes that psychedelics are not a "silver bullet," but tools that require strong systems of care, thoughtful policy, and community support to be integrated responsibly into healthcare and society.   In this episode, you'll hear: How public attitudes toward psychedelics have shifted over the past decade Major milestones that expanded psychedelic policy reform beyond federal drug approval The promises and pitfalls of increased visibility, commercialization, and hype in the psychedelic field What the recent federal executive order on psychedelics actually does and does not do An explanation of right-to-try laws, FDA approval pathways, and the complexities of rescheduling psychedelic medicines Why maintaining rigorous evidentiary standards is essential for the long-term credibility of psychedelic medicine MAPS' vision for the future of psychedelic access, including regulated adult use, professional education, and community safety infrastructure How psychedelic policy reform could evolve to include broader systems of mental health care, crisis response, and social healing   Quotes: "[Federal funding for psychedelic research] will only be so effective unless there is a massive reinvestment in mental health, harm reduction, and social services that actually ground—and one could say integrate—this medicine into like the continuum of care and the fabric of community that people are actually in." [25:07] "Even though those of us in the psychedelic advocacy field do want to see drugs like MDMA and others be approved by the FDA for medical use in these controlled clinical settings… At the same time, we don't want medical access to be accelerated so much that it's at the expense of public health or consumer protection or an evidentiary standard that other drugs are being held to." [37:59] "Medical professionals are not just prescribing things because they're approved. Many of them want to look at the evidence themselves. They want to look at the clinical trials. They want to understand 'is this the right choice for my patient?' But you can only know if [psychedelics] are being held to a comparable standard." [39:31] "What's MAPS' vision for ten years from now or 40 years from now for that matter? I like to think of it as lots of on ramps and lots of off ramps. It's that people who are seeking access to psychedelics for any beneficial purpose—for their own treatment or healing, for their own spiritual growth, for their personal development, for their for improving of their relationships with their loved ones or with nature or with spirituality, whatever that cosmology is that they hold—that they have safe, responsible methods of doing so." [44:47]   Links: Ismail on Instagram Psychedelic Medicine Association Porangui

Dr. T flies solo in this episode and hosts guest Otto Maier in a discussion on psychedelic therapy through depth psychology and lived experience. Otto describes his early work with ayahuasca and a pivotal, overwhelming initiation with 5 MeO DMT that led to a prolonged spiritual and psychological crisis. Instead of framing the experience as positive or negative, though, he emphasizes the meaning it held for him. It taught him, among other things, the importance of preparation, appropriate dosing, and trauma-informed facilitation. Dr. T and Otto unpack psychedelic healing within a harm reduction framework while challenging simplified narratives often found in the field. The discussion examines the tension between clinical models that prioritize symptom reduction and a soul-oriented approach to healing. Otto draws on Jungian psychology and archetypal theory to describe how psychedelic experiences can unfold as nonlinear processes that disrupt identity and access deeper layers of the psyche. Dr. T and Otto suggest that meaningful transformation may include disorientation and existential questioning, rather than immediate improvement, which points to limitations in current research practices. Together, they also explore the cultural divide between Western models of control and more relational, animistic perspectives. Psychedelic work is framed as an invitation to engage with uncertainty, embodiment, and the unconscious, countering the dominant concepts of cognition and productivity. The episode advocates for an integrated approach of both scientific rigor and soul-based inquiry, emphasizing ethical responsibility and the complexity of medicine-assisted healing. “I think that the soul work is something that gets us in touch with the nature of our being. And I think it includes a bit of mystery.”  - Otto Maier __ Contact Punk Therapy: Patreon: Patreon.com/PunkTherapy Website: PunkTherapy.com Email: info@punktherapy.com   Contact Truth Fairy:  Email: Truth@PunkTherapy.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Psychiatrist and longtime psychedelic researcher Scott Shannon, MD, CEO of the Board of Psychedelic Medicine and Therapies, and founder of Wholeness Center, discusses how a new federal push to accelerate psychedelic therapies could reshape the future of mental health care.

Got a show or guest idea? Send us a text!Find Kris here: https://www.t1rx.com/Mama Trauma kit: https://www.gorillaammo.com/product/gorilla-medical-mama-trauma-kit/ Kris is a board-certified physician assistant & graduated from the Army's Interservice Physician Assistant Program in 2014. He is a former Special Forces A-Team Member Medical Specialist (18D) & held multiple operational & medical advisory positions within the U.S. Special Operations Command since 2005.T1Rx was born from the harshest environments on Earth—battlefields where the margin for error is zero. Our protocols were refined to keep warriors strong, sharp, and alive.Now, we bring that same relentless standard to men who are fighting their own battles every day—at work, in the gym, at home, and in their heads.We're not here to coddle. We're here to calibrate.To work with Erin, visit: https://heartwinghealing.comNutramedix HerbsTeresa Holler, MS, PA-C, introduced these amazing products on the podcast. Code: REMEDY for 10% OFFDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showEnjoying the Show?Your comments, likes and shares make an immense difference! Please take a moment to rate, like and comment or head on over to Instagram for giveaways! @remedyrevolutionpodcast

In this episode, Jamie sits down with Paula Berry, a licensed clinical social worker, trauma specialist, and cancer survivor, to talk about the emotional side of cancer that often goes unspoken.Paula shares her personal experience with colorectal cancer, including treatment, life-altering surgery, and the unexpected mental health challenges that followed. Together, they explore what emotional survivorship really looks like, navigating depression, anxiety, identity shifts, and the pressure to “get back to normal.”They also discuss the importance of community, how to find the right therapist, and why support beyond medical treatment is essential. Paula introduces psychedelic-assisted therapy, including psilocybin, and explains why it's being studied as a potential tool for addressing cancer-related distress.It's a reminder that healing after cancer is not just physical, it's emotional, too.researchThe difference between recreational and therapeutic useResources Mentioned:Sierra Psychedelic Society: https://www.sierrapsychedelic.org/Nevada Coalition for Psychedelic Medicine: https://www.nevadacpm.org/Johns Hopkins University (psychedelic research): https://www.hopkinspsychedelic.org/In Waves and War (documentary): https://www.inwavesandwarfilm.com/

Do you feel stuck on your healing journey? In this episode, I talk with Liz Zhou, LPC about the benefits of psychedelic medicine for highly sensitive people and:  • The three steps to safely and meaningfully experience psychedelics in a therapeutic context  • How to find a provider, which medicine to choose, and the importance of advocating for your sensory and emotional needs along the way • What you can learn about yourself throughout the experience Liz is a highly sensitive & neurodivergent therapist based in Colorado. She specializes in helping highly sensitive, neurodivergent adults & couples heal their nervous systems and connect with their authentic selves, using brain-body modalities like: EMDR, Brainspotting, IFS, & Psychedelic Integration. Prior to becoming a therapist, Liz worked as a shaman's translator & ceremony facilitator at plant medicine centers in Peru & Ecuador. Currently, Liz provides therapy services in Colorado & coaching services worldwide. Keep in touch with Liz: • Website: https://www.seasonsofgrowthcounseling.com  • Instagram: https://www.instagram.com/liz.holistic.therapist  • Youtube: https://www.youtube.com/@Liz-Zhou  Resources Mentioned: • Psychedelic Prep & Integration Guide: https://www.seasonsofgrowthcounseling.com/psychedelic-guide  • Third Wave Directory: https://thethirdwave.co/directory  • Elemental Psychedelics Directory: https://www.elementalpsychedelics.com/facilitator-directory  • Polaris Insight Center: https://www.polarisinsight.com  For more deep conversations like this, join me in Sensitive Circles - a cozy online community for highly sensitive people to find meaningful connection and deepen self-awareness at their own pace. More details: https://www.sensitivecircles.com Thanks for listening! You can read the full show notes and sign up for my email list to get new episode announcements and other resources at: https://www.sensitivestories.comYou can also follow "SensitiveStrengths" for behind-the-scenes content plus more educational and inspirational HSP resources: Instagram: https://www.instagram.com/sensitivestrengths TikTok: https://www.tiktok.com/@sensitivestrengthsYoutube: https://www.youtube.com/@sensitivestrengthsAnd for more support, attend a Sensitive Sessions monthly workshop: https://www.sensitivesessions.com. Use code PODCAST for 25% off. If you have a moment, please rate and review the podcast, it helps Sensitive Stories reach more HSPs! This episode is for educational purposes only and is not intended as a substitute for treatment with a mental health or medical professional.  Some links are affiliate links. You are under no obligation to purchase any book, product or service. I am not responsible for the quality or satisfaction of any purchase.  

On this episode of Men Talking Mindfulness, hosts Jon Macaskill and Will Schneider sit down with Jonathan Dickinson, one of the most respected Ibogaine clinicians in the world. This conversation is a masterclass in brain health, psychedelic medicine, trauma, and what's actually happening in the field right now... without the hype.Jonathan walks Jon and Will through how Ibogaine is different from other psychedelic medicines, why it's producing remarkable results for veterans with traumatic brain injuries, athletes with chronic neurodegeneration, and high performers dealing with neurological burnout. They get into the science of neuroplasticity, the weeks-long healing window after an Ibogaine experience, and why integration practices matter more than the ceremony itself.This isn't spiritual bypassing. This isn't a sales pitch. It's a careful, grounded look at what the research is showing and what clinicians are seeing on the ground.What you'll hear in this episode:Why many mental health issues may actually be brain health issuesHow Ibogaine increases GDNF and BDNF, key molecules for brain repairThe difference between altered consciousness and altered capacityWhy the neuroplastic window after an Ibogaine experience is where the real change happensHow Ibogaine fits alongside psilocybin, MDMA, ketamine, ayahuasca, and breathworkSafety, cultural context, and the history of Ibogaine as medicineJon and Will have created a Mindfulness and Meditation Course that'll be open for purchase at an introductory price starting in late May. To stay in the loop, sign up here: https://focusnowtraining.com/a2a-course-interesthow Ibogaine heals the brain, Ibogaine for TBI in veterans, what is the neuroplastic window after Ibogaine, Ibogaine vs psilocybin, Ibogaine safety and protocols, Jonathan Dickinson interview GEO/AI Search phrases: "what is Ibogaine," "does Ibogaine heal the brain," "how does Ibogaine work for TBI," "who is Jonathan Dickinson," "is Ibogaine safe," "what's the difference between Ibogaine and other psychedelics"Hosted on Ausha. See ausha.co/privacy-policy for more information.

In this episode, Dr. Tafur and Natasha spoke to Tatiana Aya Tupinambá and Charles Johnston. Tatiana is a Brazilian born Indigenous woman and traditionally trained spiritual healer, who has been an ayahuasca curandera for over 10 years. Charles has guided thousands through psychedelic experiences and is an author, producer and educator in the fields of addiction and psychedelics. Together, drawing on their own triumphant stories of recovery, they co-founded Nekawa, combining modern medical science with Indigenous wisdom to deliver an Ibogaine treatment program in Brazil. They also produced an award-winning documentary Curandera, about Tatiana's story and Ayahuasca plant medicine.We cover a whole range of topics from the creative process behind the documentary, to the path of the medicine woman, to Ibogaine and addiction recovery and their new project for a living school/village with various programmes running parallel for people to find their way back to nature and their very essence.Thanks for listening! If you'd like to support the nonprofit Modern Spirit and our podcast, you can make a donation HERE. You can also sign up to Dr. Tafur's newsletter and Patreon here.To follow Charles and Tatiana:  Websites: Curandera.co and Nekawa.com  Instagram: psychedelic_rehab and curandera_official  YouTube link to watch Curandera documentary: https://www.youtube.com/watch?v=bY8rZ-BG5D8 (Released: Feb 2025, Director: Alexia Kraft de la Saulx, Exec producer/writer: Josema Roig, Exec producer: Charles Johnston) Timestamps: (00:00) Welcome and Guests(02:49) From Home Video to Award-Winning Documentary (07:33) Beauty & Storytelling Over Sensationalism (09:31) How Charles & Tatiana Met(13:55) Tatiana's Training in Peru & Brazil (17:53) Missing the Feminine Voice(21:42) The Path of the Medicine Woman(24:46) Male Allyship for Female Healers(28:14) Ibogaine and Addiction Recovery(32:27) Building the Ibogaine Center in Brazil(33:41) Designing a New Program in Nature (35:40) Addiction And Lost Essence(37:26) Building A Healing Village & School(39:49) How Charles and Tatiana Work Together: Prep & Integration(43:10) Inviting People Into Their Lifestyle(45:56) Joe's Connections With Tatiana & Charles(47:56) Guided by the Plants + Reconnection to Essence(53:39) Psychedelic Medicine & Sacred Plant Medicine Learn From Each Other(57:15) Remembering Maestro Juan Flores (01:00:03) Closing Gratitude & How to Follow Their Work

Send us Fan MailWater Tower Research's healthcare equity analyst Robert Sassoon breaks down President Trump's executive order on therapeutic psychedelics, examining the five key mechanisms it puts in place — from accelerated FDA review vouchers and right-to-try expansion to federal funding and ibogaine pathway clearance. Sassoon explains what the order gets right, where it falls short (namely on reimbursement and rescheduling), and which companies — including Compass Pathways, Dephinium Therapeutics, and Helus Pharma — stand to benefit most as the sector gains its first clear federal endorsement as a legitimate therapeutic class. 

LEARN about Sean McCormick - seanmccormick.com Dr. Fernando Vega is the most experienced Medical Doctor in the treatment of addiction, PTSD and depression with the African plant medicine Ibogaine. Here are his stories. Find him here. https://seattlehealingarts.com/fernando-vega-1 LEARN about Dry Fasting - dryfastwithfriends.com WATCH this episode on Youtube here - https://youtu.be/F0_7NMNtaS8 00:00 Introduction to Psychedelic Therapy 02:50 Dr. Vega's Journey and Experience 05:53 The Use of Psychedelics in Treatment 09:01 The Medical Board and Ethical Dilemmas 12:00 The Role of Ibogaine in Healing 14:50 Comparing Indigenous and Medical Approaches 18:00 Understanding Ibogaine's Effects 21:08 Real-World Applications of Psychedelic Medicine 24:03 The Importance of Intent in Healing 27:02 Navigating the Healing Landscape 35:49 Facing Trauma and Unconsciousness 36:28 The Role of Psychedelics in Spiritual Awakening 38:34 The Importance of Integration After Experiences 40:55 Lifestyle Changes Post-Awakening 42:04 Community Support in Integration 45:36 Navigating Change in Relationships 49:36 The Impact of Recent Legislation on Psychedelic Research 56:33 Concerns Over Medicalization of Psychedelics 01:01:34 Case Studies and Personal Experiences with Ibogaine

The modern psychedelic renaissance is teaching us something important, not just about psychedelic substances, but about how healing actually happens. Beyond the molecules, psychedelic science is revealing the conditions under which the human nervous system becomes capable of change.This episode explores the idea that psychedelics have long functioned as teachers, not only through ingestion, but by showing us how context, meaning, and state shape healing. By looking across history, neuroscience, and clinical research, we ask what psychedelic wisdom offers people who may never use a psychedelic drug at all.In this episode, we cover:Psychedelics as ancient teachers through indigenous and ceremonial traditionsWhat modern neuroscience reveals about neuroplasticity, psychological flexibility, and meaning-makingWhy preparation, set, setting, and integration matter as much as pharmacology in therapeutic outcomesNon-drug pathways that open windows of change, including meditation, mindfulness, nature exposure, and dream statesExploratory experiences that can feel truly psychedelic, such as breathwork, ritual, childbirth, and near-death experiencesHow the psychedelic movement serves as a mirror for modern medicine and challenges intervention-based models of healing

In this episode Amy Della Rocca, PMHNP joins to discuss Spravato, the FDA-approved prescription esketamine nasal spray, and its place in the field of psychedelic medicine. Amy is a psychiatric nurse practitioner and the Clinical Director of Marpa, a Spravato treatment center in New York. In this conversation, Amy offers a grounded and practical look at Spravato as one of the most accessible forms of psychedelic medicine currently available, especially for patients with treatment-resistant depression who may be priced out of intravenous or intramuscular ketamine treatments. She explains how insurance coverage, prior authorizations, and the 2025 shift allowing Spravato to be used as monotherapy have expanded access, while also walking through what treatment actually looks like in practice - from REMS monitoring and nasal spray administration to maintenance schedules and the importance of outside therapeutic support. Throughout, Amy emphasizes that Spravato can produce a wide spectrum of psychedelic effects, that it should not be dismissed as a "lesser" medicine because it is FDA-approved or pharmaceutical, and that the most effective treatment happens in a relational container that balances medical safety, emotional support, and realistic expectations about what the medicine can and cannot do.   In this episode, you'll hear: What Spravato is and how it differs from other forms of ketamine treatment How insurance coverage, Medicaid, and copay assistance can make psychedelic care more financially accessible Which two diagnoses Spravato is approved to treat Why the 2025 approval of Spravato as a monotherapy meaningfully changed patient eligibility What a typical Spravato session looks like, including dosing, REMS monitoring, and maintenance treatment Why therapy, integration support, and external community can strongly influence treatment outcomes How patients' experiences can range from subtle relaxation to deeply psychedelic states Why stigma within psychedelic spaces can invalidate ketamine experiences - and why Amy argues that needs to change What makes a patient a good candidate for Spravato treatment How clinicians can carefully work with complex cases, including suicidality, trauma histories, and bipolar depression   Quotes: "Generally we have Medicaid covering [Spravato treatments]. We have no co-pays on that or maybe it's a five-dollar co-pay. With some insurances, if there's a big deductible, they will have to pay the deductible like other treatments." [6:38] "In 2025, the FDA changed that requirement [to be on an antidepressant to receive Spravato treatments]. And now Spravato is… approved for monotherapy. So, as you know, so many of the people that are coming to us are not taking daily antidepressants because they've had terrible side effects. Or… they've felt worse, it increased their [suicidal ideation] or, you know, whatever it was. And so to have them still have to take one just felt like the wrong thing to do." [8:34] "I would say 30% of the patients continue [regular Spravato treatments] on some level—40% maybe of maintenance. And that can be every two weeks; it can be every week. There are plenty of folks that find that the glutamate activity of this medicine helps them more than anything they've ever taken and so they end up tapering off of other meds and continue to get weekly sessions with us." [14:28] "This treatment feels, in a way, like a half-treatment without outside therapy" [15:25]   Links: Amy on LinkedIn Marpa Minds website Journey Clinical website Psychedelic Medicine Association Course: Managing Medical Risk in Patients Seeking Psilocybin Therapy Previous episode: Ending Pill Shaming: How Psychedelics and Pharmaceuticals Can Both Support Healing with Erica Zelfand, ND Previous episode: Ketamine Therapy Explained: The Science Behind Mental Health Treatment with Dr. Jason Wallach Psychedelic Medicine Association Porangui

Psychedelic medicine is moving fast. Faster than regulation. Faster than standardization. And in many ways, faster than the data itself.In this episode, we explore what psychedelics are teaching us about practicing medicine under uncertainty. From the rapid rise of training programs and self-identified experts, to the tension between lived experience, emerging science, and clinical responsibility, this conversation looks beyond hype or skepticism.Drawing on psychedelic research, integrative medicine, and historical parallels like psychotherapy, biofeedback, and hormone therapy, this episode asks a deeper question: how do we determine expertise in an emerging field? And what does responsible leadership look like when certainty would be premature?This is an invitation to steward a powerful field with humility, honesty, and care.Psychedelics are teachers, let's let them teach us. 

Dane Stevens, Founder, CEO, and Director at Optimi Health, a Canadian company that manufactures MDMA and naturally derived psilocybin from mushrooms for use in therapy for PTSD and treatment-resistant depression. These psychedelic-based mental health treatments are being used in the regulated market in Australia and in Special Access programs in Canada, and showing real-world evidence of a positive impact. Dane emphasizes the importance of a clinical setting for the administration of psychedelic medicines and integration with traditional therapy. Dane explains, "We exist to support the responsible use of psychedelic medicines within regulated healthcare systems. We are a manufacturer of both MDMA and psilocybin, and our company exports those products to the only truly regulated market in the world right now, which is Australia. There, our MDMA is being prescribed for PTSD, and our psilocybin, naturally derived psilocybin extract, is being prescribed for treatment-resistant depression. And so we're not your classic drug developer. We're on a mission to be in the clinic and inpatient today, and that's where we are."   "Right now, they're still scheduled substances, but in Canada specifically, you have what's called the Special Access Program, where if you're suffering from end-of-life distress or PTSD in a very serious way or treatment-resistant depression, you can apply directly to the health minister for an exemption to access psychedelics. But they are still scheduled and restricted." "If you're looking at just the Australian model in Australia, they rescheduled specifically MDMA for the use in PTSD treatment. Specifically, around psilocybin, it's only to be used for treatment-resistant depression. And so, when we, as a company, actually export directly from Canada to Australia, the permits say it's only to be used within that framework. So it's not a take-home medicine, it's all done within the guidance of your healthcare professional at the clinic." #OptimiHealth #PsychedelicMedicine #MentalHealth #PTSD #Depression #Innovation #Healthcare #Australia #TreatmentResistantDepression #Psilocybin #MDMA #PsilocybinTherapy #MDMATherapy #MentalHealthInnovation #FDAApproval #HealthPolicy #CanadaHealth #ClinicalResearch #RealWorldEvidence optimihealth.ca Download the transcript here  

Dane Stevens, Founder, CEO, and Director at Optimi Health, a Canadian company that manufactures MDMA and naturally derived psilocybin from mushrooms for use in therapy for PTSD and treatment-resistant depression. These psychedelic-based mental health treatments are being used in the regulated market in Australia and in Special Access programs in Canada, and showing real-world evidence of a positive impact. Dane emphasizes the importance of a clinical setting for the administration of psychedelic medicines and integration with traditional therapy. Dane explains, "We exist to support the responsible use of psychedelic medicines within regulated healthcare systems. We are a manufacturer of both MDMA and psilocybin, and our company exports those products to the only truly regulated market in the world right now, which is Australia. There, our MDMA is being prescribed for PTSD, and our psilocybin, naturally derived psilocybin extract, is being prescribed for treatment-resistant depression. And so we're not your classic drug developer. We're on a mission to be in the clinic and inpatient today, and that's where we are."   "Right now, they're still scheduled substances, but in Canada specifically, you have what's called the Special Access Program, where if you're suffering from end-of-life distress or PTSD in a very serious way or treatment-resistant depression, you can apply directly to the health minister for an exemption to access psychedelics. But they are still scheduled and restricted." "If you're looking at just the Australian model in Australia, they rescheduled specifically MDMA for the use in PTSD treatment. Specifically, around psilocybin, it's only to be used for treatment-resistant depression. And so, when we, as a company, actually export directly from Canada to Australia, the permits say it's only to be used within that framework. So it's not a take-home medicine, it's all done within the guidance of your healthcare professional at the clinic." #OptimiHealth #PsychedelicMedicine #MentalHealth #PTSD #Depression #Innovation #Healthcare #Australia #TreatmentResistantDepression #Psilocybin #MDMA #PsilocybinTherapy #MDMATherapy #MentalHealthInnovation #FDAApproval #HealthPolicy #CanadaHealth #ClinicalResearch #RealWorldEvidence optimihealth.ca Listen to the podcast here  

Our understanding of how psychedelics work has evolved in meaningful ways over the past several years. While earlier neuroscience frameworks helped move the field forward, newer research has added important nuance and depth to how we interpret brain imaging, network behavior, and subjective experience.In this episode of The Trip Lab, I offer a refresh on psychedelic neuroscience, focusing on key updates from the past four years and how they change the story we tell about what's happening in the brain and the body during psychedelic states.We explore:How the Default Mode Network is better understood as dynamically modulated rather than simply reducedWhy psychedelic brain states are best described as time-varying and network-based rather than staticHow neural entropy is now understood as increased flexibility through relaxed constraintsWhy brain, body, and context are inseparable in shaping psychedelic experiences and outcomesThis episode is designed to update earlier explanations, clarify what has changed, and highlight why the newer neuroscience offers a more accurate and more interesting framework for understanding psychedelic effects.

Dr. T and Truth Fairy return for a conversation exploring the psychological and cultural dimensions of healing during times of global tension and uncertainty. Opening with a poem by Joy Harjo, they examine the themes of craving, power, and disconnection, drawing parallels between collective conflict and the inner struggles carried within the psyche. Dr. T introduces the idea of a deeper “war of consciousness,” where domineering and extractive patterns of thinking collide with emerging ecological and relational awareness. Through a trauma-informed lens, Truth Fairy and Dr. T consider how large-scale conflict may mirror unresolved trauma within individuals and societies.  The discussion then turns toward inner violence, dissociation, and the unconscious processes that can surface during medicine work. Dr. T and Truth Fairy explore how trauma fragments the psyche and creates dissociated parts that hold powerful emotions like rage, grief, and fear. Instead of encouraging cathartic discharge or attempts to eliminate these feelings, Truth Fairy emphasizes slowing down and developing the capacity to witness difficult internal states with honesty and compassion. This somatic and relational perspective highlights how healing will often emerge not from forcing change but from allowing space for experience to move and integrate naturally. Throughout the episode, Truth and Dr. T emphasize that psychedelic healing is not only an individual pursuit but part of a broader relational and cultural process. They reflect on the long arc of psychological undoing that accompanies deep trauma work and discuss the patience required to process experiences stored within the body and psyche. Sharing stories about forgiveness, accountability, and compassion, they illustrates how medicine work can cultivate greater empathy and boundaries, and nurture relational maturity. Ultimately, Dr. T and Truth Fairy suggest that the deeper purpose of psychedelic exploration may be learning to hold complexity and humanity with greater care. “In a dark medicine journey, people sometimes ask, ‘Why is this happening to me?' And I think, how could it not be there? All of that darkness lives in us already, epigenetically and ancestrally. The real question is whether we have the heart strength to turn toward it.”  - Truth Fairy __ Contact Punk Therapy: Patreon: Patreon.com/PunkTherapy Website: PunkTherapy.com Email: info@punktherapy.com   Contact Truth Fairy:  Email: Truth@PunkTherapy.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Let us know what you think!In this episode of the Security Halt! Podcast, host Deny Caballero speaks with retired Green Beret Martin Acosta, a veteran advocate focused on raising awareness about alternative approaches to mental health recovery.Martin discusses the growing conversation around psychedelic medicine, plant medicine, and trauma healing, while emphasizing the importance of education, responsible use, and strong community support systems.In This Episode• The mental health challenges facing many veterans • Why some veterans are exploring plant medicine and psychedelic therapies • The importance of education and responsible integration • The role of community in healing and recovery • The evolving conversation around veteran mental healthChapters:00:00 Why Veteran Mental Health Conversations Are Changing 02:53 Martin Acosta's Journey from Green Beret to Advocate 06:10 Understanding Psychedelic Medicine and Plant Medicine 08:54 The Role of Education and Responsible Use 11:49 Community Support in Veteran Healing 14:59 Making Informed Decisions About Mental Health 18:01 The Personal Journey of Recovery and Growth 26:55 Personal Transformation and Healing 29:50 Alternative Approaches to Pain and Trauma 32:58 Advocating for Veteran Mental Health Awareness 36:57 Embracing the Reality of the Healing Process 43:57 Finding Strength Through Difficult Experiences 50:32 Living Fully After TraumaSupport the showProduced by Security Halt Media

Send us Fan MailKabir Nath is Chief Executive Officer of Compass Pathways  ( https://compasspathways.com/ ), a biotechnology company pioneering evidence-based psychedelic innovation for serious mental health conditions.Kabir brings nearly three decades of leadership experience across the biopharmaceutical and medical device industries. Before joining Compass, he served as Senior Managing Director of Global Pharmaceuticals at Otsuka Pharmaceutical Co., and previously as President and CEO of Otsuka's North America Pharmaceutical Business, where he led the development of therapies and digital solutions addressing complex mental health needs. Earlier in his career, he held senior leadership roles at Bristol Myers Squibb.Under Kabir's leadership, Compass has advanced COMP360 — a synthetic, proprietary formulation of psilocybin — through two pivotal Phase 3 trials in treatment-resistant depression. The program has demonstrated statistically significant and clinically meaningful reductions in depression severity, potentially positioning COMP360 to become the first FDA-approved psilocybin-based treatment.Kabir holds an MA from the University of Cambridge and an MBA from INSEAD.#PsychedelicMedicine #Psilocybin #DepressionTreatment #MentalHealthInnovation #CompassPathways #COMP360 #TreatmentResistantDepression #Biotech #Neuroscience #FutureOfPsychiatry #ClinicalTrials #MentalHealthResearch #PsychedelicTherapy #BiotechInterview #DrugDevelopmentSupport the show

We are delighted to host Rose Uzunova on this episode of the Mangu.tv podcast series. Rose is currently chief community officer at the Psychedelic Science of Funders Collaborative PCFC, where she cultivates a network of informed, connected philanthropists to drive systemic change in psychedelic science. Previously, she spent over 15 years in finance, including roles on Wall Street, before transitioning into philanthropy and impact-driven community building. As an unreasonable mentor, she merges her financial acumen with heart-centred leadership, fostering collaboration and innovation in global, social and scientific initiatives. Her background combines strategic vision, fundraising capacity and a deep interest in advancing psychedelic research through community funding and advocacy.Rose reflects on her childhood in communist Bulgaria, filled with arts and self-discovery. She speaks about her transition to a more academic environment, and her decision to move to Wisconsin, which gave her better social, academic and professional opportunities. Rose discusses her time in finance with top firms like Morgan Stanley and BlackRock, before her interests shifted towards spiritual healing and psychedelics. She shares her first experience with Ayahuasca and her journey with The Medicine of the Four Directions. Giancarlo and Rose speak about the use of psychedelic medicine and the need for therapy and careful integration. They highlight the importance of creating safe spaces for psychedelic use, ensuring thorough medical history assessments, follow-ups, and integration support. Rose shares her life's purpose, to be a channel for dharmic work for the benefit of all beings' happiness and freedom from suffering.

Can drugs like ketamine, LSD, and marijuana really “rewire” the brain?In this episode of The Long Form Podcast, Dr. Lisa Ndejuru, clinician at the King Faisal Hospital Ketamine Treatment & Research Centre in Kigali, breaks down the science and controversy surrounding psychedelic-assisted therapy, mental health treatment in Africa, and the global rise of ketamine clinics. We discuss Elon Musk's public use of ketamine, Silicon Valley's investment in psychedelics, African traditional plant medicine, marijuana culture among young Africans, and whether modern pharmaceuticals are healing trauma — or simply reshaping perception. Sponsors:Threat Informat - https://threatinformant.io/.                                                    Akagera Medicines- https://www.akageramedicines.com/ Join our Patreon to enjoy ad-free viewing https://www.patreon.com/cw/TheLongFormPod or support us via our MTN Mobile Money Code 95462 or directly to our phone number: +250795462739 Visit Sanny Ntayombya's Official Website: https://sannyntayombya.com

Psychiatrist, internist, and addiction medicine specialist Muhamad Aly Rifai discusses his article "Psychedelic-assisted therapy: science, safety, and regulation." Muhamad explores the complex landscape of psychedelic medicine, balancing the growing public interest with the necessity of rigorous FDA oversight and safety protocols. The conversation examines the distinction between classic psychedelics like psilocybin and dissociatives like ketamine while highlighting why "set and setting" are critical for therapeutic success in treating depression and trauma. Muhamad emphasizes that these powerful agents are not simple pill swaps but require structured psychological support to translate peak experiences into lasting behavioral change. Discover why the path to effective treatment relies on transparent regulation and clinician humility rather than unsupervised experimentation. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

In this episode, Hunt Priest joins to discuss the intersection of psychedelic experiences and religion. Hunt is the founder of Ligare: A Christian Psychedelic Society and was a participant in the Johns Hopkins/NYU Psilocybin Study for Religious Leaders in 2016. The epiphanies he had at Hopkins forever changed the trajectory of his work and led him to start Ligare in 2021. In this conversation, Hunt Priest reflects on how participating in the Johns Hopkins study reshaped his understanding of Christianity, embodiment, and spiritual experience. Drawing on his background as an Episcopal priest, he explores the deep resonance between psychedelic experiences and Christianity, arguing that non-ordinary states of consciousness have always been central to religious life, even if institutional churches have often marginalized them. The discussion ranges from spiritual emergence and theological disruption to healing, discernment, and the role clergy can play in preparation and integration. Hunt also shares his own profound embodied experience during the study where he encountered Vedic and Upanishadic concepts firsthand. He explains how it ultimately led him to found Ligare, a Christian psychedelic society aimed at bridging psychedelics, healing, and the Christian mystical tradition.   In this episode, you'll hear: Hunt's ideas of how psychedelic experiences connect with Christian sacraments and liturgical practices How psychedelics connect with understandings of religious pluralism and the diversity of spiritual experiences Resources for working through ideas that psychedelic experiences could be sinful or demonic Hunt's thoughts on navigating theological disruption, spiritual emergence, and expanded images of God Why embodiment and bodily wisdom are central to spiritual insight and healing The vital opportunity institutional religion risks missing in the current psychedelic renaissance   Quotes: "I think there's a lot of us [clergy] out there that understand that the spiritual issues that come up with psychedelics are important and need to be tended to in a sensitive way—in an open minded way, an open hearted way." [14:36] "The Church has, over time, taught people to not trust their minds or their bodies. And that's a huge mistake because our bodies keep the score and they also are one of the places we hold wisdom—which was the biggest lesson I got from the first experience I had at Hopkins." [17:39] "That's why the spiritual care professionals could be so important: when these issues, these spirit big spiritual questions or even a collapse of your own theological framework happens, you need help to put it back together. And just like therapy helps us put our emotional life back together, I think a good spiritual director or spiritual advisor—one-on-one or small group work—can help us put our theology back together." [21:47]   Links: Ligare website Ligare on Instagram Hunt on Instagram Hunt on LinkedIn Center for Action and Contemplation website Previous episode: Avoiding the Pitfalls of Psychedelic Medicine with Matthew Johnson, PhD Psychedelic Medicine Association Porangui  

Michael Bogenschutz, MD, explains how psychedelic-assisted treatments may offer new options for patients with severe, treatment-refractory psychiatric conditions. He discusses why standard approaches often fall short for complex cases, how psychedelics like psilocybin and MDMA differ from conventional medications, and what careful screening and clinical structure make these treatments safe and effective.Drawing on randomized clinical trials and years of clinical experience, Dr. Bogenschutz describes how psychedelic treatments can produce durable symptom improvement in disorders such as alcohol use disorder and trauma-related conditions. He also explores unresolved scientific questions, including whether the psychedelic experience itself is necessary for therapeutic benefit.Michael Bogenschutz, MD, is Professor of Psychiatry and Director of the Center for Psychedelic Medicine at NYU Langone Health.▶️ Watch Insights on Psychiatry on YouTube00:00 A Remarkable Case: Sustained Sobriety After Psilocybin Treatment00:39 Introducing Dr. Michael Bogenschutz01:04 Why Psychiatry Is Re-Examining Psychedelics02:50 Safety, Screening, and Managing the Psychedelic Experience03:45 Landmark Trial: Psilocybin for Alcohol Use Disorder06:16 How Psychedelics Work: Neuroplasticity vs. Subjective Experience08:53 Can Non-Psychedelic Analogs Deliver the Same Benefits?11:47 MDMA, Fear Reduction, and Emotional Processing13:44 Who Benefits Most? A Composite of Treatment-Refractory Patients15:45 The Future of Psychedelic Psychiatry at NYUThis episode is intended for psychiatrists, mental health clinicians, and others interested in complex and treatment-resistant psychiatric conditions.This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle

Why do psychedelic experiences so often feel spiritual, sacred, or life-changing? Why are mystical-type experiences so closely linked to lasting therapeutic benefit? And why does medicine struggle to talk about them at all?In this episode, we explore the neuroscience and psychology behind mystical experiences in psychedelics. We examine how shifts in brain networks involved in meaning, identity, and self-referential thinking can give rise to experiences of unity, insight, and transcendence, and why these subjective moments may matter more than the drug itself.A grounded exploration of what psychedelic science is revealing about meaning, consciousness, and healing.

The Netflix documentary “In Waves and War” reveals the stunning results of psychedelic therapy and how medicines like Ibogaine and 5-MeO-DMT are proving to help warriors overcome their demons, which all too often drive them to suicide. Former Navy SEAL Chief Anthony Rivera completed this groundbreaking treatment back in 2020 and shares vivid memories from his experience. We start with a gripping look at what life on the SEAL teams was like, and the troubling after effects of combat. After attempting to fight the battle alone, Rivera was eventually convinced by a fellow team mate to undergo a powerful medically assisted session in Mexico, thanks to Veterans Exploring Treatment Solutions. Rivera described in detail, the vivid images and feelings he experienced during the sessions. And he shared the profound connection between psychedelic therapy and feeling the presence of God. As the medicine coursed through his veins, the results that he and hundreds of other Special Operations veterans experienced, are nothing short of miraculous. Rivera also makes a powerful case for why psychedelic therapy is more effective than traditional mental health treatment and the overwhelming number of medications widely prescribed. Now a devout Christian, Rivera continues to serve his fellow veterans through his company Vetavize, which helps them navigate the VA benefit claims process, and receive the benefits they earned. Watch In Waves and War on Netflix https://vetsolutions.org/news/netflix-in-waves-and-war-vets/ For more on Medical Psychedelic Therapy Sessions, check out Veterans Exploring Treatment Solutions (VETS) here: https://vetsolutions.org/ For VA claims assistance using AI-powered Vetavize, Connect with SEAL veteran, Anthony Rivera here: https://vetavize.com/ To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

In this episode, Matthew W. Johnson, PhD returns to discuss how psychedelics can be leveraged to catalyze human agency. Dr. Johnson has been at the forefront of psychedelic research for 21 years, having conducted seminal research on the effects of psilocybin on mystical experience, personality, and treatment of cancer distress, major depressive disorder, and tobacco addiction. His work with tobacco addiction received the first federal funding for a classic psychedelic in the modern era of research. In this conversation, Dr. Johnson explores psychedelics as powerful enhancers of human agency—the felt capacity to steer one's own life, make meaningful choices, and act from a place of inner autonomy. Drawing from two decades of research across depression, cancer distress, addiction, and healthy volunteer studies, he argues that increases in agency may be a core, yet under-recognized, mechanism behind therapeutic change. Dr. Johnson discusses agency as a "meta-executive" function intertwined with free will, mental flexibility, and meaning-making, and suggests that psychedelics may uniquely illuminate and strengthen this capacity. In closing, he shares thoughts on how individuals can better take advantage of psychedelic-induced neuroplasticity to increase agency in their own lives.   In this episode, you'll hear: What Dr. Johnson means by "agency" and why he sees it as central to psychedelic healing Clinical examples of participants who rediscovered autonomy, changed behaviors, or reframed their suffering after psilocybin sessions Why psychedelics may enhance big-picture psychological flexibility, not just moment-to-moment cognitive flexibility How increased agency may help people with depression, addiction, and cancer distress shift entrenched patterns of thinking and behavior Potential future research directions for studying the neuroscience of agency   Quotes: "It's not just that enhancing agency is the elephant in the room of why psychedelics are working, it's also that I think psychedelics can be a tool for finally understanding this thing of human agency." [4:31] "Even if you think the sense of free will is an illusion, it has to be an evolutionarily advantageous illusion. Why else would it be seemingly universal?" [12:30] "When someone really has one of these 'ah-ha' experiences, they can really come to this perspective of 'no, no, no, no, no, I really am choosing how I'm thinking about myself.' In cancer [patients] it happened a lot." [21:51]   Links: Previous episode: The Latest Research on Psilocybin for Depression with Matthew Johnson, PhD Previous episode: Exploring DMT Entities with Matthew Johnson, PhD Previous episode: Avoiding the Pitfalls of Psychedelic Medicine with Matthew Johnson, PhD Dr. Johnson on X Dr. Johnson on InstagramDr. Johnson on LinkedIn Psychedelic Medicine Association Porangui

One on One Video Call W/George https://tidycal.com/georgepmonty/60-minute-meetingSupport the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USThe Lila Code: https://orcid.org/0009-0008-4612-3942

In this episode, Psychedelic Medicine Podcast host, Dr. Lynn Marie Morski, provides the latest updates from the field of psychedelic medicine. Dr. Morski discusses the breakthrough therapy designation which a number of psychedelic compounds have received in the past few years, the most recent of which is BPL-003, a nasal spray formulation of 5-MeO-DMT. One of the exciting aspects of this new compound, Dr. Morski notes, is that it is shorter-acting than most serotonergic psychedelics—a feature which may make treatment with this substance less expensive and more accessible.  Another exciting development is the COMPASS Pathways phase 3 trial of COMP360 psilocybin. Dr. Morski shares that the company believes they are nine to twelve months ahead of schedule, which means that if all goes well, this psilocybin compound could be approved for treatment resistant depression as early as sometime in 2027. She also discusses why the US FDA said they rejected MDMA for PTSD and what this governing body would like to see from subsequent research before reconsidering this decision. In closing, Dr. Morski shares excitement about the development of novel psychoplastogens—the non-hallucinogenic psychedelics—which may help bring many of the same healing benefits to populations currently unable to be served by the existing compounds under investigation.   In this episode, you'll hear: Which psychedelics currently have breakthrough therapy designation and for which indications Details of recent ketamine research for inpatient depression care and why these results are not as negative as they may seem The current horizons of psychedelic research and what indications may soon be explored Sources of hope in the current state of psychedelic research and the legal landscape   Quotes: "[BPL-003] showed rapid and durable antidepressant outcomes after a single dose. … here we have something that is under an hour [of psychedelic experience] for treatment resistant depression." [7:43] "Keeping patients blinded to whether or not they got the placebo or MDMA is a big focus that [the FDA] wanted to emphasize for these future phase 3 trials." [19:07] "I know we had a big setback last year. I think a lot of us thought by this time we'd be a year into MDMA being approved and we're not. However, there are so many things on the horizon that are worth being excited about." [23:48]   Links: Psychedelic Medicine Podcast on Instagram Psychedelic Medicine Podcast on YouTube Jelovac A, McCaffrey C, Terao M, et al. "Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression: The KARMA-Dep 2 Randomized Clinical Trial" JAMA Psychiatry, 2025. Beckley Psytech Limited Phase 2 Trial: BPL-003 Efficacy and Safety in Treatment Resistant Depression COMPASS Pathways Phase 3 Trial: Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD Food and Drug Administration (FDA) Complete Response Letter (CRL) to Lykos Therapeutics, declining to approve MDMA-assisted therapy for Posttraumatic Stress Disorder Psychedelic Alpha Psychedelic Drug Development Bullseye Chart Psychedelic Medicine Association Porangui

In this rerun episode of BS Free MD, Drs. May and Tim Hindmarsh revisit one of their most transformative conversations — with Dr. Lida Fatemi, an internal medicine physician, palliative and hospice expert, and leader in the responsible use of psychedelic medicine for trauma healing and burnout recovery.Dr. Fatemi shares her extraordinary story — from growing up during war and oppression in Iran to becoming a national voice on mental health, trauma, and consciousness in medicine. Together, they explore how unresolved trauma manifests as burnout, the moral injury in modern medicine, and how psychedelic-assisted therapy (including psilocybin and LSD) can serve as tools for emotional and spiritual healing when approached responsibly.The discussion takes listeners through:Dr. Fatemi's immigration journey and early life in Iran under a repressive regime.The turning point in her medical career that led to burnout — and her awakening to deeper purpose.The role of psilocybin and psychedelic-assisted coaching in rewiring trauma patterns.Misconceptions about psychedelics, safety considerations, and what “conscious life practices” mean.The intersection of faith, healing, and self-rediscovery in becoming whole again.This powerful conversation blends science, spirituality, and humanity — inviting listeners to consider what true healing looks like beyond symptom management and system metrics.ABOUT THE GUESTDr. Fatemi is an award-winning academic physician specializing in internal medicine, palliative care, and hospice medicine. She is the founder of Conscious Physician, a psilocybin-assisted coaching and certification program for healthcare professionals facing burnout. Her bestselling book Thriving After Burnout and her forthcoming title Trauma to Self-Love explore how conscious practices and plant medicine can help professionals reconnect to meaning, joy, and balance.Connect with Dr. Fatemi:

In this conversation, Kelsi Sheren and Dr. Mike Hart discuss various pressing issues in the Canadian healthcare system, focusing on mental health, transgender care, childhood vaccines, and the use of psychedelic medicine. They explore the implications of affirming mental illness, the responsibilities of the healthcare system, and the challenges faced by patients seeking alternative treatments. The discussion also highlights the bureaucratic hurdles in accessing necessary medical care and the need for a more patient-centered approach in healthcare. In this conversation, Kelsi Sheren and Dr. Michael Hart discuss the pressing issues within the Canadian healthcare system, including access to care, the impact of ideology on medical practices, and the challenges faced post-COVID. They delve into the controversial topic of Medical Assistance in Dying (MAID) and its implications, particularly for vulnerable populations. The discussion also highlights the importance of mental hdealth, the role of suffering in healing, and the need for preventative health measures, especially concerning dementia. The conversation emphasizes the necessity for patient empowerment and the advocacy for better treatment options in the healthcare system.FOLLOW: https://mikehartmd.com@drmikehartHART2HART PODCAST - https://tr.ee/gbtcMSUBYdChapters00:00 Introduction and Context01:09 Mental Health and Societal Issues03:20 Transgender Care and Healthcare Responsibilities05:57 Mental Health Treatment and Medication12:55 Vaccination Concerns and Political Dynamics19:11 Psychedelic Medicine and Treatment Resistance31:10 Navigating Psychedelic Therapy and Legal Hurdles36:01 The Shocking Proposal: Electroshock Therapy vs. Psilocybin39:43 The Bureaucratic Barriers in Healthcare44:51 The Crisis of Access to Medical Care in Canada50:50 The Ideological Shift in Medical Practice01:00:48 The Future of Healthcare: Concerns and Accountability01:02:30 The Right to Choose: Vaccination and Medical Beliefs01:05:38 Understanding Medical Labels and Identity01:09:37 The Journey of Recovery: Mental Health and Diabetes01:13:04 The Reality of Suffering and Societal Expectations01:15:57 Exploring Dementia: Treatment and Quality of Life01:20:47 The Ethics of Medical Assistance in DyingSupport the show here! - https://paypal.me/brassandunitySubscribe, like and comment! Let's connect!Instagram -   /thekelsisherenperspective/X: /KelsiBurns Substack:  https://substack.com/@kelsisherenTikTok -   /thekelsisherenperspectiveListen on Spotify - https://open.spotify.com/show/1O3yiobOjThKHtqyjviy1a?si=0d6670ff32d74359Apple Podcasts - https://podcasts.apple.com/ca/podcast/the-kelsi-sheren-perspective/id1537489127SUPPORT OUR SPONSORS - - - - - - - - - - - -Ketone IQ- 30% off with code KELSI - https://ketone.com/KELSIGood Livin - 20% off with code KELSI - https://www.itsgoodlivin.com/?ref=KELSIBrass & Unity - 20% off with code UNITY - http://brassandunity.com - - - - - - - - - - - - -CHARITYHeroic Hearts Project - https://www.heroicheartsproject.orgAll Secure Foundation - http://allsecurefoundation.orgDefenders of Freedom -https://www.defendersoffreedom.usBoot Campaign - https://bootcampaign.org

A school principal abruptly quits his 20-year career, then spirals into suicidal depression, before finding a complete transformation after experimenting with psilocybin mushrooms, frog venom, and MDMA. Hope Lives Here is a production of Voyage Media. The series is produced by Nat Mundel and Dan Benamor. This episode was executive produced by Michael (which is not his real name), and story produced by Sophie Lee. Starring Jonathan Regier as Michael and Roshelle Simpson as Charlotte. Original music by Derlis Gonzalez. Edited, sound designed, and mixed by James Scully. If you're enjoying the show, please leave us a 5-star review on Apple Podcasts, or anywhere you're listening, and subscribe now for future episodes. Learn more about your ad choices. Visit megaphone.fm/adchoices

For years, traditional therapies have fallen short for veterans battling the invisible wounds of war: PTSD, depression, and anxiety. Now, there's a new path forward. Join us on this episode of the DAV Podcast as we dive into the groundbreaking world of psychedelic-assisted therapy. From this year's National Convention, Matt Saintsing hosts a panel exploring this innovative shift in mental healthcare. At DAV, we're not just supporting this research—we're actively advocating for it to bring hope and healing to those who have given so much.

In this solo episode, I'm diving deep into a crucial topic that doesn't get talked about enough: how to differentiate between fear and danger when working with psychedelics.This episode was inspired by my coach training at iPEC and the powerful concept of Fearlessness—the idea that fear is a projection of the mind, not a present-moment truth.Understanding the difference between fear and danger can literally be the difference between a transformative psychedelic experience and a traumatizing one. And the line between the two is not always clear—especially when psychological or energetic safety is involved.Topics Covered: Why fear is natural (and even healthy) when approaching psychedelic workHow danger shows up in the psychedelic space—from unsafe facilitators to inadequate screeningClear examples of fear vs. danger in ceremony settingsWhy mistaking one for the other could cost you transformation—or your safetyHow prep coaching can help you work with fear and protect yourself from dangerSupport the show and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠become a subscriber⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for just $4.99/mo!As a subscriber, enjoy ad free and intro free episodes, early access to new episodes + a monthly bonus podcast.Explore Coaching with Lana:Iboga Integration & Prep Coaching⁠⁠⁠ (NEW-now enrolling)Psychedelically Informed Life Coaching⁠⁠⁠ (6 Month Program)Stay Connected to Modern Psychedelics:Instagram: ⁠⁠⁠@modernpsychedelics⁠⁠⁠YouTube: ⁠⁠⁠Modern Psychedelics YouTube⁠⁠⁠Website: ⁠⁠⁠www.modernpsychedelics.net⁠⁠⁠Substack: The Healthy Ego⁠⁠Free Resources:FREE Iboga Preparation Guide⁠FREE Set Better Goals⁠FREE Integration Journal ⁠FREE Intention Setting Journal⁠FREE Psychedelic Ceremony Checklist⁠FREE Playlists for Psychedelic Journeys + Integration⁠DISCLAIMER: Modern Psychedelics does not endorse or support the illegal consumption of any substances. This show is meant for entertainment purposes only. Modern Psychedelics does not sell or promote the sale of any illegal substances. The thoughts, views, and opinions on this show should not be taken as life advice, medicinal advice, or therapeutic guidance.

Alex Grey is an American visual artist, author, teacher, and Vajrayana practitioner known for creating spiritual and psychedelic artwork such as his 21-painting Sacred Mirrors series. He works in multiple forms including performance art, process art, installation art, sculpture, visionary art, and painting. He is also on the board of advisors for the Center for Cognitive Liberty and Ethics, and is the Chair of Wisdom University's Sacred Art Department. He and his wife Allyson Grey are the co-founders of The Chapel of Sacred Mirrors (CoSM), a non-profit organization in Wappingers Falls, New York.Allyson Grey, a conceptual abstract painter and co-founder of CoSM, Chapel of Sacred Mirrors, has long been a mentor and influencer of the contemporary Visionary Art movement. In 1971, in a psychedelic awakening through the guidance of Ram Dass' book Be Here Now, Allyson heard a voice calling her to express in her art an essentialized world view. Chaos, Order & Secret Writing came to artistically symbolize the three essential characteristics of human perception, a minimal yet all-encompassing artistic statement worthy of immersion for a lifetime. Allyson's art is a personal and shared meditation on the structure of thought, life and enlightenment.Episode Highlights▶ The origin story of the Sacred Mirrors and the creation of CoSM▶ How LSD catalyzed Alex and Allyson's personal and spiritual awakening▶ Why creativity is a spiritual practice and a gateway to soul's purpose▶ The transformative power of psychedelics on healing and self-awareness▶ Why staying creative every day is key to manifesting your soul's work▶ Art as evidence of your inner vision and a path to service▶ The role of intention, commitment, and patience in creative fulfillment▶ Creativity as essential medicine for a disconnected society▶ Psychedelics and relationships: how shared experiences deepen intimacy▶ The future of CoSM and the long-awaited opening of EntheonAllyson & Alex Grey's Links & Resources▶ Allyson and Alex Grey / CoSM: https://www.cosm.org/▶ Alex Grey's website: https://www.alexgrey.com/▶ Allyson Grey's website: https://www.allysongrey.com▶ CoSM YouTube:  https://www.youtube.com/channel/UCZVxulrA3TWY1_WSeFD3eGg  Download Beth's free trainings here: Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business: https://bethaweinstein.com/grow-your-spiritual-businessIntegrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services▶ Instagram: @bethaweinstein ▶ FB: / bethw.nyc + bethweinsteinbiz ▶ Join the free Psychedelics & Purpose Community: / psychedelicsandsacredmedicines

A conversation with Henna Maria on plant medicine, spiritual sovereignty, and the fight for authentic healingThe psychedelic renaissance is here—but are we losing the soul of the medicine in the process?In this powerful episode, I sit down with Henna Maria, human rights activist and founder of Dawn of Peace, to explore one of the most critical conversations of our time: the difference between sacred ceremony and clinical commodification in psychedelic healing.Henna brings a rare perspective—12 years living with indigenous communities in Peru, direct experience with plant medicine traditions, and unflinching activism on the frontlines of medical freedom. Her message is urgent: we're at a crossroads where the pharmaceutical industry threatens to strip the spirit from these sacred medicines, just as they did with cannabis.What You'll DiscoverThe Sacred vs. The SyntheticWhy context matters more than compound—and how the Western medical model fundamentally misunderstands what these medicines are for.The Real Risks of "Democratized" PsychedelicsFrom spiritual attachments to energetic parasites—what happens when you open your consciousness without proper protection and guidance.Ancestral Wisdom Meets Modern HealingHow Henna's journey from European activism to Amazonian apprenticeship led her back to Finland to revive her own cultural roots.Beyond Individual HealingWhy true regeneration requires moving from personal transformation to collective cultural revival—and what that looks like in practice.The Stakes Are Higher Than You ThinkThis isn't just about psychedelics. It's about spiritual sovereignty—our right to connect directly with the divine without corporate intermediaries. It's about honoring indigenous wisdom instead of extracting and commodifying it. It's about understanding that healing isn't a product you consume, but a sacred relationship you cultivate.As Henna puts it: "When you take an entheogenic, you put a red light on in the spirit world saying 'Hello, I'm here.' If you don't have a ceremonial space to protect you, you're wide open and all manner of things can jump in."A Call to Conscious ActionWhether you're curious about plant medicine, already walking this path, or simply care about the future of healing, this conversation will challenge you to think deeper about:* What makes medicine truly sacred vs. merely therapeutic* How to honor indigenous wisdom without appropriating it* The role of ceremony, community, and cultural context in healing* Why the fight for medical freedom is ultimately spiritualThis is regenerative culture in action—where we invite you to discover new/ancient ways of living that not only heals the self but it also benefits all life. Check out our full Regenerative Culture Website for our workshops, programs, courses and retreats. And stay updated with the latest by subscribing to our newsletter.Listen now and join the conversation about what authentic medicine looks like in the 21st century.Connect with Henna Maria:Dawn of Peace: https://dawnofpeace.org/Instagram: @hennamaria22Continue the Conversation:What's your experience with sacred vs. clinical approaches to healing? Share your thoughts in the comments below.Regenerative Culture Chronicle is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.If this resonates, please share it with someone who needs to hear this message. The future of conscious healing depends on these conversations happening in community, not isolation.(This description summary was written in collaboration with Claude.ai)#PsychedelicMedicine #SacredActivism #RegenerativeCulture #SpiritualSovereignty #PlantMedicine #ConsciousHealing Get full access to Regenerative Culture Chronicle at regenerativecultureworld.substack.com/subscribe

In this Mission Matters episode, Adam Torres interviews Doug Drysdale, CEO of Cybin, about the groundbreaking work his company is doing to develop psychedelic-based treatments for mental health conditions. From clinical trials to regulatory challenges, Doug shares his mission to transform suffering into healing through next-generation therapeutics. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

Beth Weinstein's Links & Resources▶Free Spiritual Business & Psychedelic Business Trainings: https://bethaweinstein.com/gifts▶ Beth's other Business Coaching Programs: https://bethaweinstein.com/services▶ Beth's Instagram: http://instagram.com/bethaweinstein▶ Beth's Facebook: https://www.facebook.com/bethw.nyc & https://www.facebook.com/BethWeinsteinbiz▶ Join Beth's free Psychedelics Facebook Community: https://www.facebook.com/groups/PsychedelicsandSacredMedicines▶ Various Psychedelic Training Programs and Resources: https://bethaweinstein.com/resources Download Beth's free trainings here: Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business: https://bethaweinstein.com/grow-your-spiritual-businessIntegrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services▶ Instagram: @bethaweinstein ▶ FB: / bethw.nyc + bethweinsteinbiz ▶ Join the free Psychedelics & Purpose Community: / psychedelicsandsacredmedicines

In this engaging episode of the Psychedelics Today podcast, host Joe Moore sits down with Karina Bashir, an attorney working at the intersection of law, business ethics, and psychedelics. Karina, of counsel with Antithesis Law and an active member of the psychedelic community, shares her unique journey from human rights advocacy into the evolving field of psychedelic law. The conversation explores her presentation at Harvard on psychedelics and monotheistic religions, and her efforts to bridge the gap between Islamic communities and psychedelic-assisted healing. She discusses the legal frameworks she navigates to support clients in the psychedelic ecosystem, the spiritual depth of Sufism, and the expansive tradition of Islamic philosophy and mysticism. If you're intrigued by the intersections of religion, law, and psychedelic healing, this episode offers deep insights and hopeful perspectives.

Charles Eisenstein is a teacher,  public speaker, and author who examines the unspoken narratives that direct our society and our lives. His work covers a wide range of topics, including the history of human civilization, consciousness, economics, spirituality, interdependence, ecology, and how myth and story influence culture. His newest book, The Coronation, was released in the summer of 2022. He is the author of The More Beautiful World our Hearts Know is Possible, Sacred Economics, and The Ascent of Humanity.Episode Highlights▶ Why “the rehearsal is over” and it's time to live our psychedelic insights▶ How feelings of despair stem from ignoring deeper truths we've already seen▶ The power of small, heart-led actions to create meaningful change▶ Why real transformation starts with connection, not productivity▶ Psychedelics as medicine for the illness of separation and disconnection▶ Integration through community and the need for collective story-holding▶ How crisis moments offer powerful opportunities for conscious choice▶ The shadow side of doomsday narratives and how to shift beyond them▶ Rethinking "right" and "wrong" in psychedelic use, cultural gatekeeping, and humility▶ How psychedelic medicine is quietly reaching power structures▶ The Sanity Project as a sanctuary for anchoring a new cultural storyCharles Eisenstein's Links & Resources▶ Website: https://charleseisenstein.org/courses/sanity-project/▶ Substack: https://charleseisenstein.substack.com/▶ Instagram: https://instagram.com/charles_eisenstein▶ Facebook:https://www.facebook.com/charleseisensteinauthor  Download Beth's free trainings here: Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business: https://bethaweinstein.com/grow-your-spiritual-businessIntegrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services▶ Instagram: @bethaweinstein ▶ FB: / bethw.nyc + bethweinsteinbiz ▶ Join the free Psychedelics & Purpose Community: / psychedelicsandsacredmedicines

Content Warning: This episode contains discussions of addiction, opioid use (including fentanyl), complex trauma, intergenerational trauma, medical neglect, and the death of a child.Dr. T and Truth Fairy welcome guest Liz Rezanson, a psychotherapist and social worker who works with the caregivers of children with disabilities, largely in her community of Vernon, BC. Liz believes in the healing power of connection and integrates mind-body attunement therapy, EMDR, EFT, hypnosis, and psychedelic-assisted therapy into her practice using a trauma-informed approach. Liz shares her deeply moving personal and professional journey through raising a daughter with catastrophic epilepsy and her oldest daughter Amy's eventual struggle with opioid addiction, including fentanyl use, and repeated treatment attempts that led to a tragic end.   Liz's story highlights the need for a more compassionate and effective approach to addiction recovery, one that acknowledges the role of attachment, emotional regulation, and support. She, Truth, and Dr. T discuss how psychedelic-assisted therapy, specifically with medicines like ibogaine and MDMA, can offer a powerful opportunity ot desensitize past trauma and support emotional integration. Liz emphasizes that healing doesn't happen through medicine alone, but through the presence of a trained and emotionally regulated facilitator and through a focus on coregulation and relational attunement. Dr. T and Truth Fairy agree with Liz in stating that her daughter Amy's journey illustrates the high stakes and systemic failures in addiction treatment, particularly when treatment centres are ill-equipped to meet clients with compassion and flexibility. Liz emphasizes that healing developmental trauma requires practitioners to develop their own capacity for emotional presence through somatic awareness and self-regulation. Her story is a powerful call to reshape psychedelic integration therapy and addiction treatment by centring safety, right-brain healing, and the profound importance of human connection.“Just that need to be so in tune or attuned to our clients, and especially in the psychedelic field. Yeah. You're doing sometimes long sits, and you have to be able to stay with it and be able to support, and I always say I'm not… I hate the term healer. I think I'm not a healer. I'm literally the guide in this process, whether it be we use something like eMDR or somatic or IFS, whatever, psychedelic, whatever we're using. I'm just the guide in the process. I'm just the person who shows you how to reconnect with yourself, right?” - Liz Rezanson About Liz Rezanson, Psychotherapist, BCYC, MACP, CCC, RSW:Liz has called Vernon home for the past 30 years, and for over two decades, she has had the privilege of working with individuals and families in that community. Her background includes more than 20 years supporting families, and 11 years working closely with children with diverse abilities and their caregivers.At the heart of her work is a belief in the healing power of connection—both with ourselves and with those closest to us. Liz works alongside my clients with compassion, curiosity, and respect, helping them move toward greater authenticity, emotional safety, and meaningful change. True connection takes courage, vulnerability, and the right kind of support. She believes it's her role to help create the space where that becomes possible.Liz offers individual, couples, and group therapy in a safe and confidential setting. She draws on a range of approaches, with specialized training in: Mind-Body Attunement Therapy®, EMDR (Eye Movement Desensitization and Reprocessing), Emotion Focused Therapy (EFT) for Couples, Psychedelic Psychotherapy (studied over the past five years), Clinical HypnosisShe takes an attachment-based, trauma-informed approach to therapy and works with clients navigating trauma, anxiety, depression, PTSD, grief, and chronic pain. In addition to psychotherapy, Liz offers parent coaching, health and wellness counselling, support for chronic pain management, and guided processing of trauma, loss, and life transitions.Contact Liz Rezanson:LinkedIn: liz-rezanson-1b26ab67Website: MindBodyCounselling.org__Resources discussed in this episode:Allan Schore“Affect Regulation and the Origin of the Self” by Allan N. ShoreDarcia Narvaez, PhD: EvolvedNest.orgInternal Family Systems (IFS) and Dr. Richard Schwartz__Contact Punk Therapy:Patreon: Patreon.com/PunkTherapyWebsite: PunkTherapy.comEmail: info@punktherapy.com Contact Truth Fairy: Email: Truth@PunkTherapy.com

On this episode, we welcome writer, philosopher, and “introspective detective” AJ Murillo to the show! We discuss her wisdom and perspective gained on psychedelic journeys and explore the subject of her most recent book: the concept of ego death as an aspect of emotional and spiritual healing. We also share some amazing stories about psilocybin guiding us deeper into our intuition, helping both of us to confirm and encourage life decisions around our partner choices and having children.For more on this subject see episode 17: Psychedelic Therapy with Robert DeSalvo LCSW in our podcast feed! Follow AJ's work and various projects here! ⁠⁠⁠⁠Psyche Magic Website, Socials and more!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit psychemagic.substack.com/subscribe

Luke Kohen is an internationally recognized speaker, touring artist, mentor and ecopreneur. Also known as a bard & community builder, he draws from over 18 years of experience in wisdom traditions, holistic business & trauma healing modalities; which have informed his life path, creative process, message & service to the whole.LK serves at the intersection of systems change, impact entrepreneurship & personal development. He is a stand for a cultural regenaiisance on the planet, weaving nation building, decolonization and shadow work into the space of leadership.Episode Highlights▶ How Luke's healing crisis at 22 sparked his path to grounded spirituality and self-responsibility▶ Why recognizing our shared humanity is key to building empathy and real connection▶ How trauma can serve as a powerful shared experience that deepens connection▶ Why true growth means integrating insights into daily life, not relying on outside fixes▶ How real societal change depends on collective healing and addressing shared wounds▶ The exciting potential of future healing tech to transform treatment and understanding▶ Why trusting the natural flow of personal and collective growth is essential during change▶ How technology can either awaken and connect us—or distract and disconnect usLuke Kohen's Links & Resources▶ Website: https://lukekohen.com/▶ Instagram: https://www.instagram.com/lukekohen/  Download Beth's free trainings here: Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business: https://bethaweinstein.com/grow-your-spiritual-businessIntegrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services▶ Instagram: @bethaweinstein ▶ FB: / bethw.nyc + bethweinsteinbiz ▶ Join the free Psychedelics & Purpose Community: / psychedelicsandsacredmedicines

Rosemary Gladstar has been practicing, living, learning, teaching and writing about herbs for over 50 years. She is the author of twelve books including Medicinal Herbs; a Beginners Guide, Herbal Healing for Women, Gladstar Herbal Recipes for Vibrant Well Being and her most recent book, Herbal Healing for Men. She is also the author and director of the popular home study course, The Science and Art of Herbalism. Rosemary co-founded and was the former director of both The International Herb Symposium and The New England Women's Herbal Conference, is the Founding President of United Plant Savers, and was the co-founder and original formulator of Traditional Medicinal Tea Company. She recently moved from her home at Sage Mountain ~ an Herbal Retreat Center and Botanical Sanctuary where she has lived, taught and worked for the past 30 years ~ to a smaller haven where she plans to plant a small garden, dream more, do less, and spend more time with the plants.Episode Highlights▶ Rosemary's early journey into the world of herbalism and how it has evolved into a recognized career▶ The crucial role of education in making the wisdom and practice of herbalism accessible to a wider audience▶ The increasing mainstream acceptance of herbalism and its integration into modern approaches to well-being▶ The important ecological responsibilities that come hand-in-hand with utilizing the power of plants for healing▶ The often profound spiritual connections and personal joy that can be found in working with and understanding plants▶ How lifestyle choices and the incorporation of plants and herbalism can address many of the health challenges of our time▶ Insights into the future of herbalism, including the potential of plant-based solutions and the wisdom shared in Rosemary's latest work, 'The Generosity of Plants'Rosemary Gladstar's Links & Resources▶ Website: https://sagemountain.com/  Download Beth's free trainings here: Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business: https://bethaweinstein.com/grow-your-spiritual-businessIntegrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services▶ Instagram: @bethaweinstein ▶ FB: / bethw.nyc + bethweinsteinbiz ▶ Join the free Psychedelics & Purpose Community: / psychedelicsandsacredmedicines

In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Dr. Raymond Turpin, a psychologist and psychedelic researcher who has been studying these medicines since 1984. Find full show notes and links here: https://thethirdwave.co/podcasts/episode-299/?ref=278 Dr. Turpin shares his journey from discovering Timothy Leary's writings as a college student to founding the Pearl Psychedelic Institute in North Carolina. He discusses his experience as one of only two sites nationwide to provide MDMA-assisted therapy through the FDA's expanded access program, the profound healing he witnessed in patients with treatment-resistant PTSD, and the challenges faced after the FDA's rejection of MDMA therapy in 2024.  Through stories of clinical breakthroughs, educational initiatives, and recovery efforts following Hurricane Helene, Dr. Turpin offers insights into the evolving landscape of psychedelic medicine and his hope for its future integration into mainstream mental healthcare. Dr. Raymond Turpin is the Executive Director and Clinical Director of the Pearl Psychedelic Institute in western North Carolina. He has been studying and researching psychedelics since 1984 and earned his doctorate in clinical psychology from the California Institute of Integral Studies. Dr. Turpin served as an investigator in an Expanded Access program providing MDMA-assisted psychotherapy for treatment-resistant PTSD and has worked with ketamine-assisted therapy while providing psychedelic integration services. Since 2022, he has been a Mentor for the Certificate in Psychedelic Therapy and Research program at CIIS. His clinical experience spans psychiatric hospitals, emergency units, residential treatment facilities, schools, and community mental health clinics. Highlights: A psychedelic calling that began in 1984 How a mushroom trip changed his career path When conventional mental health tools fall short MDMA's remarkable results with treatment-resistant PTSD From 71 to 18: Dramatic PTSD symptom reduction The FDA rejection: A devastating setback Hurricane Helene's impact on Asheville's healing community Why psychedelics threaten traditional mental health paradigms Turning trauma's irritant into a pearl of wisdom Education as resistance against misinformation Episode links:  The Pearl Psychedelic Institute The Pearl Institute YouTube channel California Institute of Integral Studies (CIIS) Certificate in Psychedelic Therapy and Research program Webinar: MDMA-Assisted Therapy for PTSD: Expanded Access & Beyond Timothy Leary's autobiography "Flashbacks" (1984) Episode Sponsor: The Intensive for Psychedelic Professionals in Costa Rica - a transformative retreat for personal and professional growth.

“Psychedelic medicine can be rocket fuel for healing,” explains Nick Brüss, EdD, LMFT. Brüss, licensed psychotherapist in Los Angeles specializing in integrative, ketamine-assisted psychotherapy, and Internal Family Systems, joins us today to discuss the healing power of psychedelic medicine, the therapeutic uses, plus:  - What is  psychedelic therapy (~2:03) - Use cases for psychedelic therapy (~7:15) -  MDMA, psilocybin, ketamine (~9:12) - Set & setting (~12:08) - MDMA (~15:35) - Ketamine (~21:33) -  Psilocybin (~27:40) - Opening up to the experience (~29:20) - Exclusion criteria (~32:10) - Age & brain development (~33:50) - Choosing a practitioner (~37:17) - Non-psychadelic modalities (~41:22) - Where is the science headed (~47:40) - What Brüss is most excited about (~49:55) - Closing thoughts (~52:50) Referenced in the episode:  - Check out his website (https://apracticeoffreedom.com/)  - Follow him on Instagram (@drnickbruss)  - Research by MAPS on MDMA (https://maps.org/mdma/ptsd/phase3/)  Set your kid's night routine up for success with Hyland's sleep-supporting gummies and sugar-free liquids. These multi-benefit formulas are made with or without melatonin to ease occasional sleeplessness while also supporting calm and immune health—so the whole family snoozes better.*‡ Learn more at hylands.com. We hope you enjoy this episode, and feel free to watch the full video on YouTube! Whether it's an article or podcast, we want to know what we can do to help here at mindbodygreen. Let us know at: podcast@mindbodygreen.com. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. ‡ For occasional sleeplessness. Learn more about your ad choices. Visit megaphone.fm/adchoices

A cutting-edge exploration of the role of psychedelics in the end-of-life experience• Outlines 10 steps for dying gracefully with the help of psychedelics, including how to navigate the complex legal landscape and find the right guide and therapy• Looks at clinical studies of psychedelics from UCLA, Johns Hopkins, and NYU School of Medicine that show dramatic lessening of end-of-life anxiety in terminally ill patients• Shares wisdom from experts on psychedelic research and palliative care, including Roland Griffiths, Katherine MacLean, Ira Byock, and Anthony BossisExamining the evolving landscape that is found around end-of-life psychedelic care, Dr. Richard Louis Miller, a clinical psychologist for more than half a century, looks at how LSD, MDMA, psilocybin, and ayahuasca can be vital tools in allowing individuals in all stages of life to confront fears of dying and, in so doing, lead richer lives.Miller shares wisdom from experts on the frontiers of psychedelic research and palliative care—including Roland Griffiths, Katherine MacLean, Ira Byock, and Anthony Bossis—and examines cutting-edge studies from Johns Hopkins, UCLA, and NYU School of Medicine that show dramatically decreased anxiety in terminally ill patients through the use of psychedelics. He explores how different substances can help the dying overcome their end-of-life distress. He also provides testimony from researchers and patients participating in psychedelic-assisted psychotherapy that helps convey the experience of ego death at the heart of the psychedelic experience.Miller outlines 10 steps for dying gracefully, without fear, with the help of psychedelics. He examines how to navigate the complex legal landscape and find the right guide, dose, and therapy. He also includes reflections from key figures in the psychedelic community as well as some of his own psychedelically informed mystical and near-death experiences.Revealing psychedelics as a portal of transformation, Miller shows how they are singularly valuable in helping individuals face the end of life with courage and serenity.Richard Louis Miller, M.A., Ph.D., has been a clinical psychologist for more than 60 years. He is host of the internet radio broadcast Mind Body Health & Politics, the founder of the internationally acclaimed Cokenders Alcohol and Drug Program, and creator of the Health Sanctuary at Wilbur Hot Springs. He has been a faculty member at the University of Michigan and Stanford University and an advisor on the President's Commission on Mental Health. He lives in Fort Bragg and Wilbur Hot Springs, California.https://www.drrichardlouismiller.com/Become a supporter of this podcast: https://www.spreaker.com/podcast/earth-ancients--2790919/support.

Join Nick Lamagna on The A Game Podcast with our guest Ian McCall, former UFC Fighter who has turned his focus to healing brain, physical and emotional trauma through alternative medicines such as psychedelics and peptides.  He is an athlete, entrepreneur, business owner, podcast host, comedian, coach and one of the most well known OG's in the professional fight game. This lifelong martial artist fought the baddest men in the biggest organizations in combat sports and now helps to develop a more resilient and resourceful mindset when facing stressful and traumatic life challenges in and out of competition. Since his retirement, he has become one of the most prominent advocates for the decriminalization of psilocybin and its safe use in the professional sports healing and performance arena.  He credits psilocybin and plant medicines  for successfully overcoming his decades of dependence on pain medication.  Through his Coaching platform known today as The McCall Method he does Psychedelic consulting and runs a non-profit called Athletes Journey Home.  Topics for this episode include: ✅ Vulnerable stories coming up fighting in the UFC ✅ Potential healing properties of psychedelics to heal brain trauma ✅ Misconceptions of alternative drug treatments and microdosing  ✅ The pros and cons of Peptides and BPC-157 ✅  The future of modern medicine + More See the show notes to connect with all things Ian! Connect with Ian McCall: Ian McCall on Facebook Ian McCall on Instagram Ian McCall on Twitter Ian McCall on LinkedIn     Connect with The McCall Method: themccallmethod.com The McCall Method on Instagram The McCall Method on Twitter The McCall Method on TikTok   Connect with The Athletes Journey Home: athletesjourneyhome.com Athletes Journey Home on Instagram         --- Connect with Nick Lamagna www.nicknicknick.com Text Nick (516)540-5733 Connect on ALL Social Media and Podcast Platforms Here FREE Checklist on how to bring more value to your buyers

Sam Harris speaks with Dr. Jennifer Mitchell and Dr. Sarah Abedi about recent developments in research on psychedelics. They discuss the history of this research and the war on drugs, recent setbacks in the FDA approval process, MDMA as a treatment for post-traumatic stress disorder (PTSD), the challenges of conducting this research, allegations of therapist misconduct, new therapeutic models for mental health treatment, psychoneuroimmunology, "non-psychedelic" psychedelics, good and bad trips, the FDA's coming decision on MDMA-assisted therapy, "right-to-try" policies for pharmaceuticals, the role of psychedelic therapists, the problem of having all this therapeutic work being done underground, and other topics. Petition to approve MDMA-assisted therapy for PTSD: https://www.approvemdmatherapy.com/ If the Making Sense podcast logo in your player is BLACK, you can SUBSCRIBE to gain access to all full-length episodes at samharris.org/subscribe.   Learning how to train your mind is the single greatest investment you can make in life. That's why Sam Harris created the Waking Up app. From rational mindfulness practice to lessons on some of life's most important topics, join Sam as he demystifies the practice of meditation and explores the theory behind it.